Bioceres Crop Solutions (BIOX) Projected to Post Earnings on Thursday

Bioceres Crop Solutions (NASDAQ:BIOX) will likely be releasing its Q1 2027 resultson Thursday, November 12th. Analysts expect the company to announce earnings of $0.02 per share for the quarter. Individuals may visit the company’s upcoming Q1 2027 earnings results page for the latest details on the call scheduled for Thursday, November 12, 2026 at 8:30 AM ET.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Tuesday, September 15th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.33). Bioceres Crop Solutions had a negative return on equity of 39.11% and a negative net margin of 94.76%. The company had revenue of $55.90 million during the quarter, compared to analysts’ expectations of $79.00 million.

Bioceres Crop Solutions Stock Performance

NASDAQ:BIOX opened at $0.25 on Thursday. Bioceres Crop Solutions has a 12-month low of $0.19 and a 12-month high of $2.03. The stock has a 50-day moving average price of $0.34 and a 200 day moving average price of $0.46. The company has a current ratio of 0.81, a quick ratio of 0.63 and a debt-to-equity ratio of 0.94. The stock has a market capitalization of $16.17 million, a P/E ratio of -0.07 and a beta of 0.54.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Friday, October 9th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $2.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions.

Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.